Adamas Pharmaceuticals Inc

CIK 1328143 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Adamas Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Feb 15, 2022SC 13G/A0001193125-22-042671
Feb 14, 2022SC 13G/A0000935836-22-000128
Jan 26, 2022SC 13G/A0001493152-22-002255
Dec 10, 2021SC 13G/A0000315066-21-001898
Dec 6, 202115-12B0001104659-21-146860
Dec 1, 2021EFFECT9999999995-21-004519
Nov 24, 2021S-8 POS0001104659-21-143417
Nov 24, 202125-NSE0001354457-21-001375
Nov 24, 2021S-8 POS0001104659-21-143422
Nov 24, 2021SC 14D9/A0001104659-21-143337
Nov 24, 2021S-8 POS0001104659-21-143419
Nov 24, 2021POS AM0001104659-21-143413
Nov 24, 2021S-8 POS0001104659-21-143414
Nov 24, 202140001328143-21-000087
Nov 24, 2021S-8 POS0001104659-21-143420
Nov 24, 2021S-8 POS0001104659-21-143425
Nov 24, 202140001328143-21-000091
Nov 24, 202140001328143-21-000092
Nov 24, 202140001328143-21-000088
Nov 24, 2021S-8 POS0001104659-21-143415
Nov 24, 2021SC TO-T/A0001104659-21-143352
Nov 24, 202140001328143-21-000090
Nov 24, 2021S-8 POS0001104659-21-143423
Nov 24, 202140001328143-21-000086
Nov 24, 2021S-8 POS0001104659-21-143416